A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Study sponsor: Tiziana Life Sciences LTD · TLSA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-04-01Estimated
Enrollment · participants5Estimated
Source updated2026-06-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.